United States Gynecological Devices Market Outlook to 2023

  • ID: 4228974
  • Report
  • Region: United States
  • 68 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Boston Scientific Corp
  • Cook Group Inc
  • CooperSurgical Inc
  • Ethicon Inc
  • Hologic Inc
  • MORE
United States Gynecological Devices Market Outlook to 2023

Summary

The author’s new report, "United States Gynecological Devices Market Outlook to 2023", provides key market data on the United States Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Gynecological Devices market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Gynecological Devices market.
- Key players covered include Hologic Inc, CooperSurgical Inc, Bayer AG and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Boston Scientific Corp
  • Cook Group Inc
  • CooperSurgical Inc
  • Ethicon Inc
  • Hologic Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Gynecological Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Gynecological Devices Market, United States
3.1 Gynecological Devices Market, United States, Revenue ($m), 2009-2016
3.2 Gynecological Devices Market, United States, Revenue ($m), 2016-2023
3.2.1 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.2 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.3 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.4 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2009-2016
3.2.5 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.6 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.7 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023
3.2.8 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2016-2023
3.3 Gynecological Devices Market, United States, Volume (Units), 2009-2016
3.4 Gynecological Devices Market, United States, Volume (Units), 2016-2023
3.4.1 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016
3.4.2 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2009-2016
3.4.3 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016
3.4.4 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2009-2016
3.4.5 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023
3.4.6 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2016-2023
3.4.7 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023
3.4.8 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2016-2023
3.5 Gynecological Devices Market, United States, Average Price ($), 2009-2023
3.6 Gynecological Devices Market, United States, Distribution Share by Revenue ($m), 2016
3.7 Gynecological Devices Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Gynecological Devices Market
4.1 Bayer AG
4.1.1 Company Overview
4.2 Utah Medical Products, Inc.
4.2.1 Company Overview
4.3 Hologic Inc
4.3.1 Company Overview
4.4 Ethicon Inc
4.4.1 Company Overview
4.5 Merit Medical Systems, Inc.
4.5.1 Company Overview
4.6 Boston Scientific Corp
4.6.1 Company Overview
4.7 Cook Group Inc
4.7.1 Company Overview
4.8 CooperSurgical Inc
4.8.1 Company Overview
5 Gynecological Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Hologic Acquires Cynosure in Tender Offer
7 Recent Developments
7.1 Corporate Communications
7.1.1 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members
7.1.2 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer
7.1.3 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer
7.1.4 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer
7.2 Financial Announcements
7.2.1 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year
7.2.2 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million
7.2.3 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 4: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 6: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 7: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 8: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 9: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 10: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 11: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 12: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 13: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 14: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 15: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 16: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016
Table 17: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 18: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 19: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 20: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023
Table 21: Gynecological Devices Market, United States, Average Price ($) Historic, 2009-2016
Table 22: Gynecological Devices Market, United States, Average Price ($), Forecast, 2016-2023
Table 23: Gynecological Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016
Table 24: Gynecological Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 25: Gynecological Devices Market Pipeline Products
Table 26: Hologic Acquires Cynosure in Tender Offer
Table 27: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country

List of Figures
Figure 1: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 4: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 5: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 7: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 8: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 9: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 10: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 11: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 12: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 13: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 14: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 15: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 16: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016
Figure 17: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 18: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 19: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 20: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023
Figure 21: Gynecological Devices Market, United States, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • Utah Medical Products, Inc.
  • Hologic Inc
  • Ethicon Inc
  • Merit Medical Systems, Inc.
  • Boston Scientific Corp
  • Cook Group Inc
  • CooperSurgical Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll